Literature DB >> 27964917

Clinical Significance of Positron Emission Tomography in Subcentimeter Non-Small Cell Lung Cancer.

Aritoshi Hattori1, Takeshi Matsunaga2, Kazuya Takamochi2, Shiaki Oh2, Kenji Suzuki2.   

Abstract

BACKGROUND: This study evaluated the clinical significance of maximum standardized uptake value (SUVmax) on positron emission tomography (PET) in patients with subcentimeter non-small cell lung cancer (NSCLC).
METHODS: Between 2008 and 2014, 189 patients were investigated preoperatively by PET for c-N0 subcentimeter NSCLC, and SUVmax was reviewed. Pathologic invasiveness (PI) was defined as having at least one of the following factors: lymphatic invasion, vascular invasion, pleural invasion, or nodal metastasis. Survival rates were calculated by Kaplan-Meier estimation methods using the log-rank test.
RESULTS: Mean SUVmax was 1.7 ± 1.8 (range, 0.6 to 13.0), and the median was 1.0. PI was found in 28 (15%) patients with subcentimeter NSCLC. Multivariate analysis revealed that SUVmax was an independent significant clinical predictor of PI (p = 0.0251) and a prognostic factor of overall survival (OS) (p = 0.0485). A receiver operating characteristics curve elucidated the predictive cutoff value of PI as SUVmax = 2.0. The high-SUVmax group (SUVmax >2.0; n = 42) had significantly more radiologically pure-solid lesions (91% vs 14%; p < 0.0001) and postoperative nodal involvement (12% vs 0%; p < 0.0001) than the low-SUVmax group (SUVmax ≤2.0; n = 147). The 5-year lung cancer-specific OS (LCS-OS) elucidated significant difference between the high-SUVmax and low-SUVmax arms of the study (LCS-OS: 92.3% vs 96.9%, respectively; p = 0.0054), and cancer recurrence was found exclusively in pure-solid subcentimeter NSCLC on thin-section computed tomography. In the high-SUVmax arm of the study, lobectomy was associated with better 3-year recurrence-free survival compared with sublobar resection despite the subcentimeter disease (88.3% vs 50.0%; p = 0.0453).
CONCLUSIONS: SUVmax on PET reflected tumor invasiveness and had a great impact on the prognosis of subcentimeter NSCLC, especially when a tumor showed a pure-solid appearance on a thin-section computed tomography scan.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27964917     DOI: 10.1016/j.athoracsur.2016.09.059

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Ethnic Disparities in Imaging Utilization at Diagnosis of Non-Small Cell Lung Cancer.

Authors:  Rustain L Morgan; Sana D Karam; Cathy J Bradley
Journal:  J Natl Cancer Inst       Date:  2020-12-14       Impact factor: 13.506

2.  How to manage patients with subcentimeter non-small cell lung cancer?

Authors:  Tomoyoshi Takenaka
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

3.  Non-adjacent interlobar lymph node metastasis distant from small-sized peripheral non-small cell lung cancer.

Authors:  Tomohiro Maniwa; Toru Kimura; Masayuki Ohue; Yasushi Shintani; Jiro Okami
Journal:  Surg Today       Date:  2022-04-30       Impact factor: 2.549

4.  The Contribution of Fluorine 18F-FDG PET/CT to Lung Cancer Diagnosis, Staging and Treatment Planning.

Authors:  Emine Budak; Gürsel Çok; Ayşegül Akgün
Journal:  Mol Imaging Radionucl Ther       Date:  2018-06-07

5.  Stage-Specific PET Radiomic Prediction Model for the Histological Subtype Classification of Non-Small-Cell Lung Cancer.

Authors:  Yanlei Ji; Qingtao Qiu; Jing Fu; Kai Cui; Xia Chen; Ligang Xing; Xiaorong Sun
Journal:  Cancer Manag Res       Date:  2021-01-12       Impact factor: 3.989

6.  18F-fluorodeoxyglucose uptake in PET is associated with the tumor microenvironment in metastatic lymph nodes and prognosis in N2 lung adenocarcinoma.

Authors:  Kotaro Nomura; Tokiko Nakai; Yukino Nishina; Naoya Sakamoto; Tomohiro Miyoshi; Kenta Tane; Joji Samejima; Keiju Aokage; Motohiro Kojima; Shingo Sakashita; Tetsuro Taki; Saori Miyazaki; Reiko Watanabe; Kenji Suzuki; Masahiro Tsuboi; Genichiro Ishii
Journal:  Cancer Sci       Date:  2022-02-18       Impact factor: 6.716

7.  Segmentectomy versus wedge resection for radiological solid predominant and low metabolic non-small cell lung cancer.

Authors:  Atsushi Kagimoto; Yasuhiro Tsutani; Takahiro Mimae; Yoshihiro Miyata; Morihito Okada
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-05-02

8.  Efficacy of a combined tool for stage I non-small cell lung cancer against lymph node metastasis.

Authors:  Takeo Nakada; Mitsuo Yabe; Takashi Ohtsuka
Journal:  Oncol Lett       Date:  2022-08-09       Impact factor: 3.111

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.